Answers are grounded in this paper and cite their sources.
Analysis outlines evidence quality for ductal carcinoma in situ in WHO guidelines, indicating gaps and areas for improvement.
Aim: The World Health Organization (WHO) Classification of Tumours (WCT) defines ductal carcinoma in situ (DCIS) as a non-invasive neoplastic proliferation of the mammary ductal epithelium confined by the basement membrane. This study maps the distribution and quality of evidence cited in the DCIS chapter of the 5th edition of the WCT (Breast Tumour). Methods: We appraised the full text of each citation according to study design and evidence level using two evidence stratification frameworks: the Centre for Evidence-Based Medicine (CEBM) of the University of Oxford and the newly developed Hierarchy of Evidence for Tumour Pathology (HETP). A digital interactive map of the cited evidence was developed, with citations represented by spheres in a graphical matrix of tumour type (columns) and tumour descriptors (rows). Sphere size and colour varied with quantity and evidence level, respectively. Results: We retrieved 36 publications from the DCIS chapter of the 5th WCT, observing an uneven distribution of citations across tumour descriptors. 'Pathogenesis' had the highest number of references, while 'clinical features,' 'aetiology,' and 'diagnostic molecular pathology' each had only one citation. The cited literature in the DCIS chapter was predominantly case series and appraised as low-level evidence. Only 'prognosis and prediction' had a significant proportion of moderate and high-level evidence citations. Compared to the lobular carcinoma in situ (LCIS) chapter of the 5th WCT, the DCIS chapter had a higher proportion of moderate and high-level evidence citations. Conclusion: The predominance of low-level evidence was expected given the observational and diagnosis-focused nature of pathology research. As part of the WCT EVI MAP international collaboration led by the International Agency for Cancer Research (IARC), our map synthesises evidence from the DCIS chapter of the 5th WCT to springboard future efforts to map all available evidence on DCIS and enhance the editorial process for future WCT editions. Citation Format: Clarissa Jing Wen Wong, Nur Diyana Md Nasir, Valerie Cui Yun Koh, Fiona Campbell, Stephen Fox, Sunil R Lakhani, Nickolas Myles, George Yip , Richard Colling, Ian A Cree Dilani Lokuhetty & Puay Hoon Tan. Mapping the cited evidence of ductal carcinoma in situ from the 5th edition of the World Health Organisation classification of tumours of the breast [abstract]. In: Proceedings of Frontiers in Cancer Science 2024; 2024 Nov 13-15; Singapore. Philadelphia (PA): AACR; Cancer Res 2025;85(15_Suppl):Abstract nr P78.
No takes yet. Share an insight, caveat, or question.
Wong et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: